February 2, 2015     Japanese 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania

Tokyo, Sept 2, 2009 (JCN) - Ranbaxy Laboratories, India's largest pharmaceutical, and parent Daiichi Sankyo have announced that Terapia S.A., a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication Evista in Romania. This is the first time that Daiichi Sankyo and Ranbaxy are leveraging synergies generated through the Hybrid Business Model in Europe.

With a population of 22 million people, Romania is Eastern Europe's second biggest market after Poland. Annual turnover in the Romanian pharmaceutical market totals about $2.5 billion, and the market is growing at around 20 percent a year, in local currency terms.

Established in 1921, Terapia, now Terapia Ranbaxy, has a strong brand name and a consistent track record of growth and profitability. It is the largest generic pharmaceutical company and is one of the seven largest pharmaceutical companies in Romania.

In 2006, Daiichi Sankyo acquired the marketing and distribution rights for Evista, an osteoporosis treatment, in six European countries from Eli Lilly and Company. In 2008, Daiichi Sankyo acquired additional rights for the drug covering all remaining countries in Europe, with the exception of Greece.

By Saroj Shrestha Staff Writer

Copyright © 2015 JCN. All rights reserved. A division of Japan Corporate News Network KK.

 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Daiichi Sankyo  News  
  Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria  (Aug 1, 2013)
  Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy  (Feb 15, 2013)
  Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign  (Dec 20, 2012)
  Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania  (Sept 2, 2009)
  Daiichi Sankyo Files Application for Dysuria Treatment KMD-3213 in China  (Jan 8, 2009)
  Daiichi Sankyo and Ranbaxy Move Forward Toward The Completion of the Landmark Deal  (Oct 20, 2008)
  Daiichi Sankyo's Tender Offer for Ranbaxy Ends in Success  (Oct 17, 2008)
  Shionogi to Acquire U.S. Drug Maker Sciele Pharma  (Sept 1, 2008)
  Daiichi Sankyo to Buy Indian Drug Giant Ranbaxy  (June 11, 2008)
  Daiichi Sankyo to Acquire German Biomedical Firm  (May 21, 2008)

CSR Report Download
Annual Reports

  More >>    
Most Popular

About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)